Cargando…
Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer
BACKGROUND: Expression of the dimeric M2 isoenzyme of pyruvate kinase, termed Tumor M2-PK, is increased in some human cancers. This study evaluates the potential role of pre-operative Tumor M2-PK as a marker of prognosis in patients with pancreatic malignancy. METHODS: Seventy-three consecutive pati...
Autores principales: | Bandara, Indika A., Baltatzis, Minas, Sanyal, Sudip, Siriwardena, Ajith K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853155/ https://www.ncbi.nlm.nih.gov/pubmed/29540198 http://dx.doi.org/10.1186/s12957-018-1360-3 |
Ejemplares similares
-
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
por: Goldberg, Michael S., et al.
Publicado: (2012) -
Tumor pyruvate kinase M2: A promising molecular target of gastrointestinal cancer
por: Guo, Chen, et al.
Publicado: (2018) -
O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth
por: Singh, Jay Prakash, et al.
Publicado: (2019) -
Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis
por: Zhan, Cheng, et al.
Publicado: (2015) -
Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth
por: Xiangyun, Ye, et al.
Publicado: (2016)